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Background: Antibiograms created by aggregating hospital-wide susceptibility data from diverse patients can be
misleading. To demonstrate the utility of age- and location-stratified antibiograms, we compared stratified
antibiograms for three common bacterial pathogens, E. coli, S. aureus, and S. pneumoniae. We created stratified
antibiograms based on patient age (<18 years, 18–64 years, >/=65 years), and inpatient or outpatient location using
all 2009 E. coli and S. aureus, and all 2008–2009 S. pneumoniae isolates submitted to our clinical microbiology
laboratory. We compared susceptibility rates among cumulative and stratified antibiograms using descriptive
statistics.
Findings: For E. coli and S. aureus, the institution-wide antibiogram overestimated resistance in pediatic isolates and
underestimated resistance in isolates from the elderly. For E. coli, pediatric isolates were less susceptible to
ampicillin and ampicillin-sulbactam and more susceptible to gentamicin and ciprofloxacin compared to adult
isolates (p < 0.05 for all), and isolates from patients >65 years were least susceptible to ciprofloxacin (71%). For
S. aureus, susceptibility to oxacillin, clindamycin, and levofloxacin was highest among children and decreased with
increasing age (p < .001 for all). For S. pneumoniae, pediatric isolates were less susceptible than adult isolates to all
agents except penicillin (IV breakpoint). Within children there were significant differences in susceptibility of
inpatient and outpatient isolates of E. coli but not of S. aureus or S. pneumoniae.
Conclusions: Stratified antibiograms reveal age - associated differences in susceptibility of E. coli, S. aureus, and
S. pneumoniae that are obscured by hospital-wide antibiograms. Age-stratified antibiograms have potential to
influence antibiotic selection.
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Surveillance of local antimicrobial resistance is an integral
part of antimicrobial stewardship. In many institutions,
antimicrobial resistance rates are reported using hospital-
wide, cumulative antibiograms. Cumulative antibiograms
that aggregate data across a hospital can obscure diffe-
rences among patient populations (e.g. children, adults, or
long-term care facility residents), hospital units (e.g. out-* Correspondence: Banerjee.ritu@mayo.edu
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reproduction in any medium, provided the origpatient, ward, nursery, intensive care unit), or anatomic
sites (e.g. blood, respiratory, urine). Accordingly, the
Clinical and Laboratory Standards Institute (CLSI) has
published guidelines recommending stratification of
susceptibility data by patient location (e.g. specific ward
or long term care facility), clinical service, specimen
type, or patient population (e.g. cystic fibrosis patients)
(Clinical and Laboratory Standards Institute 2006;
Hindler & Stelling 2007).
Despite publication of these guidelines and studies dem-
onstrating the utility of stratified antibiograms (Binkley
et al. 2006; Kaufman et al. 1998; Kuster et al. 2008), there. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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and reporting (Xu et al. 2012). Among 65 academic
centers in the US, two thirds combined outpatient and in-
patient isolates in their antibiograms, and half did not cre-
ate unit-specific antibiograms (Lautenbach & Nachamkin
2006). It is not clear how many institutions create age
group-specific antibiograms. A recent study reported that
6 of 10 pediatric hospitals within larger adult hospitals had
cumulative antibiograms without stratification by age
(Boggan et al. 2012).
To demonstrate the feasibility and utility of creating
stratified antibiograms at our institution, we constructed
and compared age and location -stratified antibiograms
for three common bacterial pathogens, E. coli, S. aureus,
and S. pneumoniae.
Methods
Mayo Clinic, in Rochester, MN, is a tertiary care referral
center for patients of all ages. Its children’s hospital is
not a free-standing facility, but rather a hospital within
the adult hospital. Mayo Clinic creates an institution-
wide antibiogram that aggregates susceptibility data ofTable 1 Susceptibility of E. coli, S. aureus, and S. pneumoniae
All patients <18 y









S. aureus N = 3046 N = 409




S. pneumoniae N = 499 N = 139
Penicillin (IV) 98% 97%
Penicillin (oral) 58% 45%
Ceftriaxone (non-CNS) 98% 96%





Years (y); ampicillin-sulbactam (AMP-SLB), trimethoprim-sulfamethoxazole (TMP-SMX
across all age groups.isolates from inpatients and outpatients of all ages and
specimen types. We created stratified antibiograms based
on patient age (<18 years, 18–64 years, >/=65 years),
and location of specimen collection (inpatient [IP] or
outpatient [OP]) using all 2009 E. coli and S. aureus,
and all 2008–2009 S. pneumoniae isolates. We excluded
isolates that were not tested for antibiotic susceptibil-
ities and included one isolate per patient per specimen
source. Specimen sources were blood or respiratory
(all pathogens), urine (E. coli and S. aureus), and soft
tissue and bone (S. aureus). Susceptibility was defined
using the 2009 CLSI breakpoints. Intermediate suscep-
tibility was considered nonsusceptible. X2 or Fischer’s
exact tests were used to compare susceptibility rates.
P value < 0.05 was considered statistically significant.




Comparison of the cumulative and age-stratified anti-
biograms is shown in Table 1. For E. coli, pediatricisolates by patient age, Mayo Clinic Rochester, MN
18-64 y ≥65 y p-value























), intravenous (IV), central nervous system (CNS). P-value compares differences
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sulbactam and more susceptible to gentamicin and
ciprofloxacin compared to adult isolates (p < 0.05 for all).
E. coli isolates from patients >65 years were less suscep-
tible to ciprofloxacin than were isolates from younger
patients (p < .001). There were no differences in suscepti-
bility to trimethoprim-sulfamethoxazole (TMP-SMX) or
nitrofurantoin by age.
For S. aureus, susceptibility to oxacillin, clindamycin,
and levofloxacin was highest among children and dec-
reased with increasing age (p < .001 for all). TMP-SMX
susceptibility did not change with age. For methicillin-
susceptible S. aureus (MSSA), clindamycin susceptibility
did not vary significantly by age group (84% in children,
79% in adults 18–64 years, and 81% in >65 years). How-
ever, for methicillin-resistant S. aureus (MRSA), clinda-
mycin susceptibility decreased dramatically with age (76%
in children, 43% in adults 18–64 years, 20% in >65 years).
For S. pneumoniae, pediatric isolates were less susceptible
than adult isolates to penicillin (oral breakpoint), ceftria-
xone (CNS breakpoint), tetracyclines, macrolides, and
TMP-SMX. There were no significant differences in
S. pneumoniae resistance between the adult age groups.
Location-stratified antibiogram
Location-stratified antibiograms for E. coli and S. aureus
are shown in Table 2. The institution-wide antibiogram
stratified by location, but not age, did not reveal clinic-
ally significant differences in susceptibility between IP
and OP isolates (data not shown). However, when strati-
fied by both location and age, IP E. coli isolates fromTable 2 Susceptibility of E. coli, S. aureus, and S. pneumoniae
Rochester, MN
<18 y
IP OP p-value IP
E. coli n = 39 n = 267 n = 31
Ampicillin 28% 51% 0.008 48%
AMP-SLB 30% 41% 0.19 40%
Cefazolin 77% 96% <0.001 86%
Ceftriaxone 87% 98% 0.004 93%
Gentamicin 87% 97% 0.022 89%
Ciprofloxacin 82% 96% 0.001 73%
TMP-SMX 59% 77% 0.015 74%
Nitrofurantoin 100% 99% 0.99 95%
S. aureus n = 91 n = 317 n = 53
Oxacillin or Cefazolin 77% 78% 0.88 66%
Clindamycin 81% 82% 0.78 62%
Levofloxacin 88% 91% 0.51 64%
TMP-SMX 100% 100% n/a 99%
Inpatient (IP), outpatient (OP), ampicillin-sulbactam (AMP-SLB), trimethoprim-sulfamchildren and adults 18–64 years were significantly less
susceptible to ampicillin, cefazolin, ceftriaxone, gentami-
cin, and ciprofloxacin than were OP E. coli isolates
(Table 2). In those >65 years, there were no clinically
significant differences between IP and OP E. coli
susceptibility.
In contrast, for S. aureus there were no differences in
susceptibility between IP and OP pediatric isolates, and
small but statistically significant differences between IP
and OP adult isolates. For S. pneumoniae, there were no
significant differences in susceptibility when isolates
were stratified by age and location (data not shown).
Discussion
At our institution age-stratified antibiograms for E. coli,
S. aureus, and S. pneumoniae were significantly differ-
ent from the institution-wide, cumulative antibiogram.
Within age groups, susceptibility varied by IP and OP
location at time of specimen collection for E. coli but
not for S. aureus or S. pneumoniae.
We observed, as in previous studies, that E. coli and
S. aureus isolates from children were the least drug resist-
ant, while those from patients > 65 years were the most
drug resistant (Boggan et al. 2012; David et al. 2006). How-
ever, this trend was obscured by the institution-wide
antibiogram which reported average values, thus overesti-
mating resistance in pediatric isolates and underestimating
resistance in isolates from the elderly. A high prevalence of
E. coli and S. aureus drug resistance in the elderly is well-
documented and most likely reflects greater comorbidities,
hospitalizations, and antimicrobial exposure among olderisolates by patient age and location, Mayo Clinic
18-64 y ≥65 y
OP p-value IP OP p-value
8 n = 1105 n = 499 n = 1116
57% 0.005 58% 55% 0.19
50% 0.004 52% 50% 0.51
93% <0.001 90% 92% 0.24
97% 0.01 96% 98% 0.12
93% 0.026 91% 90% 0.64
83% <0.001 73% 71% 0.38
74% 0.91 81% 74% 0.002
98% 0.15 97% 97% 0.96
3 n = 957 n = 479 n = 577
73% 0.003 52% 65% <0.001
73% <0.001 49% 65% <0.001
78% <0.001 45% 58% <0.001
99% 0.96 99% 98% 0.039
ethoxazole (TMP-SMX), oxacillin (ox), cefazolin (cef).
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for S. pneumoniae, pediatric isolates were more drug resist-
ant than adult isolates. The greater drug resistance among
pediatric S.pneumoniae isolates is probably due to the high
utilization of penicillins in children and the likelihood that
the S. pneumoniae isolates used to create the antibiogram
reflected complicated or refractory infections, since
S. pneumoniae is not routinely cultured in uncomplicated
otitis media or pneumonia.
Clinician reliance on institution-wide antibiograms
that do not accurately reflect susceptibility rates in cer-
tain patient groups might lead to inappropriate empiric
antibiotic prescribing. Overestimating resistance in pe-
diatric S. aureus or E. coli could lead to prescribing of
unnecessarily broad antibiotics in children which, in
turn, can lead to increasingly drug resistant pathogens
and C. difficile infections. For example, we have ob-
served that local providers avoid clindamycin for treat-
ment of pediatric skin and soft tissue infections because
the cumulative antibiogram reports high rates of clin-
damycin resistance. An age-stratified analysis revealed
that in our geographic region, clindamycin susceptibility
among pediatric S. aureus isolates is above 80% and this
drug remains an important therapeutic option for treat-
ment of skin and soft tissue infections, including MRSA,
in children but not in older adults. Similarly, providers
in our community have followed national trends (Copp
& Hersh 2011) by increasingly prescribing third gener-
ation cephalosporins for empiric treatment of pediatric
urinary tract infections. Prescribing of fewer broad -
spectrum agents could be encouraged by creation and
dissemination of a pediatric antibiogram demonstrating
E. coli with high susceptibility to narrow - spectrum
cephalosporins. Boggan et al. recently reported that
effective antibiotic prescribing among pediatricians, as
measured through responses to clinical vignettes, im-
proved when pediatric-specific antibiograms were pro-
vided (Boggan et al. 2012).
For elderly patients, availability of age-specific anti-
biograms that do not underestimate drug resistance is
also likely to enhance appropriate antibiotic selection,
which in turn, can optimize outcomes (Ibrahim et al.
2000). We recently determined that in our county, a
quarter of elderly patients with fluoroquinolone-resistant
E. coli infections received ineffective empiric therapy
with a fluoroquinolone and had persistent or recurrent
infections, likely due to lack of awareness among
providers about local resistance rates in this age group.
Furthermore, because residents of long-term care facil-
ities are at high risk for colonization or infection with
multidrug-resistant organisms, some have advocated cre-
ation of antibiograms specific for long-term care facility
residents (Philippe et al. 2011). However, because many
long-term care facilities lack resources to create theirown antibiograms, a more practical option may be for
providers to rely on hospital-based age-stratified anti-
biograms, as we have created.
Within age groups, we noted clinically significant
differences in susceptibility of IP and OP isolates of
E. coli but not of S. aureus or S. pneumoniae. E. coli OP
isolates were generally more drug susceptible than IP
isolates, especially among children. In contrast, for
S. aureus, differences in susceptibilities between IP and
OP isolates from children as well as adults were not
statistically significant. These findings suggest that age-
and location- stratification of E. coli, the most common
pathogen isolated in children and in urinary tract
infections in general, might be a valuable tool to guide
empiric antibiotic selection for management of pediatric
urinary tract infections.
This study has several limitations. Since it was
laboratory-based, we did not have associated clinical his-
tory and could not determine if cultures represented infec-
tion or colonization, or were community-associated vs.
healthcare-associated isolates. Although we eliminated du-
plicate isolates, our sample was also likely biased toward
patients with complicated or refractory infections and
prior antibiotic exposure, since such patients have cultures
sent more frequently than patients with uncomplicated
infections. Thus, the isolates in our collection may be
more drug-resistant than those in the general population.
Lastly, our susceptibility data reflect local epidemiology
and may not be generalizable to other geographic regions
or institutions. Despite these limitations, we demonstrate
that creation of age and location-stratified antibiograms is
feasible and valuable.
In conclusion, stratified antibiograms reveal age -
associated differences in susceptibility of E. coli, S. aureus,
and S. pneumoniae that are obscured by hospital-wide
antibiograms. Further stratification of E. coli isolates by
both age and IP or OP location may also be useful to
clinicians who manage pediatric urinary tract infections.
Although the proportion of institutions that create strati-
fied vs. cumulative antibiograms is not clear, we believe
that more facilities should create age - stratified anti-
biograms especially if they serve diverse patient groups
(i.e. are not free-standing children’s hospitals or long-term
care facilities). More research is needed to determine if
improved antibiograms can be valuable stewardship tools
that facilitate appropriate empiric antibiotic selection and
enhance surveillance of antimicrobial resistance trends
(Hebert et al. 2012; McGregor et al. 2009).
Previously presented in abstract form at the Infectious
Disease Society of America meeting, 2011, Boston, MA.Competing interest
All authors report no conflicts of interest relevant to this article.
Swami and Banerjee SpringerPlus 2013, 2:63 Page 5 of 5
http://www.springerplus.com/content/2/1/63Authors’ contribution
SS performed data analysis and drafted the manuscript. RB developed
research question and assisted with data analysis and manuscript
preparation. Both authors read and approved the final manuscript.
Acknowledgements
We thank Peggy Kohner and Dr. Robin Patel, Mayo Clinic, for providing us
with susceptibility data from the clinical microbiology laboratory at Mayo
Clinic.
Financial support
This study was funded in part by the T. Denny Sanford Pediatric
Collaborative Research Fund.
Author details
1Division of Infectious Diseases, Nemours/Alfred I. duPont Hospital for
Children, Wilmington, DE, USA. 2Department of Pediatric and Adolescent
Medicine, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA.
Received: 20 November 2012 Accepted: 13 February 2013
Published: 22 February 2013
References
Binkley S, Fishman NO, LaRosa LA et al (2006) Comparison of unit-specific and
hospital-wide antibiograms: potential implications for selection of empirical
antimicrobial therapy. Infect Control Hosp Epidemiol 27(7):682–687
Boggan J, Navar-Boggan A, Jhaveri R (2012) Pediatric-specific antimicrobial
susceptibility data and empiric antibiotic selection. Pediatrics 130:e615–e622
Clinical and Laboratory Standards Institute (2006) Analysis and presentation of
cumulative antimicrobial susceptibility test data, 2nd edn. CLSI, Wayne, PA
Copp HLSD, Hersh AL (2011) National ambulatory antibiotic prescribing patterns
for pediatric urinary tract infection, 1998–2007. Pediatrics 127:1027–1033
David M, Crawford S, Boyle-Vavra S, Hostetler M, Kim D, Daum R (2006)
Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus
isolates. Emerg Infect Dis 12:631–637
Hebert C, Ridgway J, Vekkhter B, Brown E, Weber S, Robicsek A (2012)
Demonstration of a weighted-incidence syndromic combination antibiogram:
An empiric prescribing decision aid. Infect Control Hosp Epidemiol 33:381–388
Hindler JF, Stelling J (2007) Analysis and presentation of cumulative antibiograms:
a new consensus guideline from the Clinical and Laboratory Standards
Institute. Clin Infect Dis 44(6):867–873
Ibrahim E, Sherman S, Ward S, VJ F, MH K. (2000) The influence of inadequate
antimicrobial treatment of bloodstream infections on patient outcomes in
the ICU setting. Chest 118:146–155
Kaufman D, Haas CE, Edinger R, Hollick G (1998) Antibiotic susceptibility in the
surgical intensive care unit compared with the hospital-wide antibiogram.
Arch Surg 133(10):1041–1045
Kuster SP, Ruef C, Zbinden R et al (2008) Stratification of cumulative antibiograms
in hospitals for hospital unit, specimen type, isolate sequence and duration
of hospital stay. J Antimicrob Chemother 62(6):1451–1461
Lautenbach E, Nachamkin I (2006) Analysis and presentation of cumulative
antimicrobial susceptibility data (antibiograms): Substantial variability across
medical centers in the United States. Infect Control Hosp Epidemiol 27:409–412
McGregor JC, Dumyati G, Casiano-Colon AE, Chang PJ, Klevens RM (2009) Usefulness
of antibiogram surveillance for methicillin-resistant Staphylococcus aureus in
outpatient pediatric populations. Diagn Microbiol Infect Dis 64(1):70–75
Philippe H, Darling C, Aikens G, Wargo K (2011) Development of an antibiogram
in a long-term care facility. Consult Pharm 26:829
Swami S, Liesinger J, Shah N, Baddour L, Banerjee R (2012) Incidence of
antibiotic-resistant Escherichia coli bacteriuria according to age and location
of onset: a population-based study from Olmsted County, Minnesota. Mayo
Clin Proc 87:753–759
Xu R, Polk R, Stencel L et al (2012) Antibiogram compliance in University
HealthSystem Consortium participating hospitals with Clinical and Laboratory
Standards Institute guidelines. Am J Health Syst Pharm 69:598–604
doi:10.1186/2193-1801-2-63
Cite this article as: Swami and Banerjee: Comparison of hospital-wide
and age and location - stratified antibiograms of S. aureus, E. coli, and S.
pneumoniae: age- and location-stratified antibiograms. SpringerPlus 2013
2:63.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
